Johnson & Johnson vows to open up raw data from its clinical trials in an unparalleled move toward transparency and a potential leap forward in medical data mining.
Valeant Pharmaceuticals consummates its $250 million acquisition of aesthetics maker Solta Medical after completing a tender offer of $2.92 per share for its new subsidiary.
The plaintiff in a shareholder's bid for a class action lawsuit against Unilife dismisses the complaint after no other shareholders stepped up to join the suit.
The plaintiff in a purported class action shareholders lawsuit against Unilife (NSDQ:UNIS) voluntarily withdrew the complaint after no other stockholders stepped up to join the suit.
Medinol and Ariad Pharmaceuticals launch a pair of clinical trials to examine Medinol’s NIRsupreme drug-eluting coronary stent using Ariad's ridaforolimus drug.
Unilife says it's inked a supply deal for its Ocu-ject eye drug delivery system with an unspecified pharmaceutical company.
Unilife (NSDQ:UNIS) said it signed a supply deal with an unnamed "global pharmaceutical company" for its Ocu-ject eye drug delivery device.
Valeant Pharmaceuticals agrees to a $250 million buyout of medical aesthetics company Solta Medical.